US Stock MarketDetailed Quotes
XCUR Exicure
- 29.4900
- -2.5000-7.81%
Close Nov 29 13:00 ET
- 30.0000
- +0.5100+1.73%
Post 17:01 ET
64.06MMarket Cap-14599P/E (TTM)
34.9900High29.0000Low185.73KVolume30.2400Open31.9900Pre Close5.87MTurnover16.06%Turnover RatioLossP/E (Static)2.17MShares36.000052wk High41.48P/B34.10MFloat Cap1.440052wk Low--Dividend TTM1.16MShs Float576.0000Historical High--Div YieldTTM18.73%Amplitude1.4400Historical Low31.5810Avg Price1Lot Size
About Exicure Company
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
Company Profile
SymbolXCUR
Company NameExicure
Listing DateJul 31, 2019
Founded2011
CEOMr. Paul Kang
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address2430 North Halsted Street
CityChicago
ProvinceIllinois
CountryUnited States of America
Zip Code60614
Phone1-847-673-1700
Websitehttp://www.exicuretx.com
Company Executives
- Name
- Position
- Salary
- Paul Kang
- Director, Chief Executive Officer and President
- 16.94K
- Jiyoung Hwang
- Director and Chief Financial Officer
- 16.97K
- Andy Yoo
- Director and Chief Restructuring Officer
- --
- Joshua Miller
- Chief Accounting Officer
- --
- Seung Ik Baik
- Director
- --
- Hyuk Joon Ko
- Independent Director
- 7.22K
- Minhee Eom
- Independent Director
- 5.00K
- Dongho Lee
- Independent Director
- 7.22K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data